In a recent study, researchers investigated whether clinical area could predict invasion of lentigo maligna.

A recent study found high heritability among patients with hidradenitis suppurativa (HS), suggesting a stronger than previously assumed genetic basis for this disease.

Findings from a recent study found risankizumab improved both moderate to severe psoriasis symptoms and patients’ quality of life.

Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.

Personal care product-related contact dermatitis is increasing among both men and women, according to the results of a recent study.

Findings from a recent randomized controlled trial showed a broad peroxisome proliferator-activated receptor agonist improved moderate to severe pruritus among patients with primary sclerosing cholangitis and primary biliary cholangitis.

A recent randomized controlled trial assessed the efficacy of fusidic acid cream compared with erythromycin ointment as postoperative treatment following ablative fractional CO2 laser for acne scars.

Findings from a recent study suggested body mass index did not influence the need for a skin graft among patients with hidradenitis suppurativa undergoing excision.

Findings from a recent study assessed the risk of tuberculosis, latent tuberculosis, and tuberculosis reactivation among patients treated with secukinumab.

A synthetic indolicidin analogue antimicrobial peptide with activity against Staphylococcus aureus improved dysbiosis but not the clinical signs of atopic dermatitis.